Paper3201256
Infection of the SCID-hu mouse by HIV-1.
Namikawa R and 4 others. Science, 1988. Cited by 328 papers, by iCite.
Cite this record
ConductScience Library. Infection of the SCID-hu mouse by HIV-1. Papers, record 3201256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3201256
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acquired Immunodeficiency Syndrome | Major topic |
| Disease Models, Animal | Major topic |
| HIV | Major topic |
| Animals | |
| Chimera | |
| Humans | |
| Immunohistochemistry | |
| Lymph Nodes | |
| Mice | |
| Mice, Mutant Strains | |
| Nucleic Acid Hybridization | |
| RNA, Viral | |
| Thymus Gland | |
| Transcription, Genetic | |
| Viral Proteins | |
| Virus Replication |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AR5P40RR03624-029 | NIAMS NIH HHS | United States | PubMed | PubMed | |
| CA03352 | NCI NIH HHS | United States | R01CA003352 | PubMed and NIH | NIH RePORTER |
Cited by137
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 328 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41259233 | Targeting the pDC/IFN-I axis in HIV-1 immunotherapy. | Curr Opin HIV AIDS | 2026 | https://conductscience.org/library/papers/41259233 | PubMed |
| 39948291 | A novel SIV-infection animal model based on nude mice inoculated with MT-2 cells. | Arch Virol | 2025 | https://conductscience.org/library/papers/39948291 | PubMed |
| 39609320 | Melanoma in people living with HIV: Immune landscape dynamics and the role of immuno- and antiviral therapies. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/39609320 | PubMed |
| 37567486 | Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions. | Brain Behav Immun | 2023 | https://conductscience.org/library/papers/37567486 | PubMed |
| 37111494 | The Humanized Mouse Model: What Added Value Does It Offer for HIV Research? | Pathogens | 2023 | https://conductscience.org/library/papers/37111494 | PubMed |
| 36442110 | A humanized "new-trophil" mouse to study early inflammatory processes. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/36442110 | PubMed |
| 35292858 | Humanized Severe Combined Immunodeficient (SCID) Mouse Models for Varicella-Zoster Virus Pathogenesis. | Curr Top Microbiol Immunol | 2023 | https://conductscience.org/library/papers/35292858 | PubMed |
| 34985669 | Human Hematopoietic Stem Cell (HSC)-Engrafted NSG Mice for HIV Latency Research. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/34985669 | PubMed |
| 33897659 | The Interplay of HIV-1 and Macrophages in Viral Persistence. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33897659 | PubMed |
| 33868262 | Humanized Mice for the Evaluation of Novel HIV-1 Therapies. | Front Immunol | 2021 | https://conductscience.org/library/papers/33868262 | PubMed |
| 33692812 | Building the Next Generation of Humanized Hemato-Lymphoid System Mice. | Front Immunol | 2021 | https://conductscience.org/library/papers/33692812 | PubMed |
| 32901981 | μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies. | FASEB J | 2020 | https://conductscience.org/library/papers/32901981 | PubMed |
| 32457941 | Use of Humanized Mouse Models for Studying HIV-1 Infection, Pathogenesis and Persistence. | J AIDS HIV Treat | 2020 | https://conductscience.org/library/papers/32457941 | PubMed |
| 32252791 | Benefits and limitations of humanized mice in HIV persistence studies. | Retrovirology | 2020 | https://conductscience.org/library/papers/32252791 | PubMed |
| 31722191 | The Ban on US Government Funding Research Using Human Fetal Tissues: How Does This Fit with the NIH Mission to Advance Medical Science for the Benefit of the Citizenry? | Stem Cell Reports | 2019 | https://conductscience.org/library/papers/31722191 | PubMed |
| 31644426 | Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection. | Elife | 2019 | https://conductscience.org/library/papers/31644426 | PubMed |
| 31420375 | A pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection. | J Exp Med | 2019 | https://conductscience.org/library/papers/31420375 | PubMed |
| 31375576 | Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia. | J Virol | 2019 | https://conductscience.org/library/papers/31375576 | PubMed |
| 31055732 | Pathogenic Role of Type I Interferons in HIV-Induced Immune Impairments in Humanized Mice. | Curr HIV/AIDS Rep | 2019 | https://conductscience.org/library/papers/31055732 | PubMed |
| 30148455 | TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs. | J Clin Invest | 2018 | https://conductscience.org/library/papers/30148455 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3201256
GET https://conductscience.org/api/papers/v1/3201256/cited_by?page=2